Notícias · Recifes

New approach could expand CAR T therapy from blood cancers to solid tumors

Researchers at the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute report that combining CAR T cell immunotherapy with a targeted radiopharmaceutical significantly improved tumor regression in preclinical models of neuroblastoma, a rare and

Admin Recifes 15/07/2026 2

GLP-1 'secret shopper' study finds gaps in online prescribing

Getting a GLP-1 prescription online can be quick and convenient, but new research suggests it may come with surprisingly little medical oversight. The findings are published in the journal JAMA.

Admin Recifes 15/07/2026 2

Clinical trial offers strong evidence that nerve blocks can cut opioid use after cardiac s

A clinical trial led by St. Michael's Hospital researchers found that using nerve blocks, an anesthesia technique to numb targeted areas of the body, significantly reduced opioid use after cardiac surgery—findings the authors say could reshape how the potentially addictive drugs

Admin Recifes 15/07/2026 1

Radiotherapy reprograms immune response in rare skin cancer

A new Northwestern Medicine study has discovered how radiotherapy alters the immune environment within cutaneous T-cell lymphoma (CTCL) tumors, according to findings published in the Journal of the American Academy of Dermatology.

Admin Recifes 15/07/2026 1

Five-agent AI team could speed clinical trial design using real-world patient records

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell Medicine investigators. The findings, published in N

Admin Recifes 15/07/2026 1

Researchers chart a genetic path to diagnosing pulmonary fibrosis and predicting outcomes

Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and identify which patients are at greatest risk for severe outcomes, including death or the need for a lung transplant. The findings come from a new international st

Admin Recifes 15/07/2026 1

Novel blood-based biomarker enables early lung cancer detection and prognosis prediction

A collaborative research team has identified a novel blood-based biomarker capable of detecting early-stage lung cancer and predicting patient prognosis. The findings are published in the Journal of Extracellular Vesicles.

Admin Recifes 15/07/2026 2

Gut bacteria boost immune system, help send vitamin A to T cells

Scientists at UT Southwestern Medical Center have discovered that gut bacteria help regulate the development of the body's immune system by directing the movement of vitamin A through a previously unrecognized cellular network. The preclinical findings, published in Cell Host & M

Admin Recifes 15/07/2026 1

One in five people will develop cancer in their lifetime, report finds

New findings in a report led by the American Cancer Society (ACS) reveal an urgent picture of a growing global cancer burden and underscore the lifesaving potential of stronger prevention and equitable access to care. According to Global Cancer Statistics, 2026, nearly 21 million

Admin Recifes 15/07/2026 1

Commonly used drugs show small benefit for long COVID fatigue

Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long COVID fatigue among people receiving care from specialist long COVID clinics, according to new findings from a large clinical trial led by UCL and UCLH.

Admin Recifes 15/07/2026 1

Long-term stroke data reveal stem cell therapy's safety, biological activity over years

Previously unpublished long-term clinical and imaging findings from participants treated with an induced pluripotent stem cell (iPSC)-derived neural progenitor cell therapy for chronic ischemic stroke were presented at the ISSCR 2026 Annual Meeting.

Admin Recifes 15/07/2026 1

Data highlight progress toward personalized stem cell therapy for Parkinson's disease

Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture these individualized therapies, have been presented by Jea

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes